Brian Hubbard, Ph.D. received his Doctorate in Chemistry from Brown University and completed his Postdoctoral Fellowship jointly at Harvard Medical School and Tufts Medical School.
Brian has held a number of leadership positions in the biotechnology industry including senior level positions in Process and Product Development at Genetics Institute, Inc. and Wyeth BioPharma, Inc. (currently Pfizer Inc.). He served as Director of Product Recovery at Immunex Corporation, and Director of Purification Process Development at Amgen, Inc. During his 25 years within major biopharma organizations his experience includes process development and regulatory filings supporting greater than 100 clinical stage and 8 commercial products. Brian also served for eight years as head of Technology Development and Innovation for Amgen, Inc. in Purification Process Development and Pilot Plant Operations as Scientific Executive Director. In this role he was responsible for technology development for next generation biomanufacturing technologies for Amgen’s Manufacturing of the Future program. This included upstream, harvest, and downstream technologies including single use systems, flexible manufacturing, and continuous processing technologies. He is currently Chief Executive Officer at CMC Bioprocess Consulting, LLC where he provides consulting services to the biopharma industry.